Skip to main content
. 2020 Jun 29;22:164. doi: 10.1186/s13075-020-02254-4

Fig. 1.

Fig. 1

Percentage of subjects treated with pegloticase q2w or placebo reaching GMIM criteria at 3 and 6 months in the RCTs. Number of evaluable subjects is shown for each group. The percentage of responders is shown above the bars. a Results for all GMIM criteria and b Results for all criteria except urate < 6.0 mg/dL. The statistical analysis of the data is shown in the supplementary material